Crowdonomics
This isn’t MOM JUICE’s most recent raise. Reg CF · SAFE · Feb 2025 (Closed) is more current.View latest round
MOM JUICE

Reg CF · SAFE · Aug 2023

ClosedReached targetReg CFSAFE
via WeFunderView campaign
Raised
$119.4K / $124K max
96% of ceiling · target hit day 2
Investors
189
$631.8 avg
Valuation cap
$10M
cap, not an agreed valuation

Raised over time

Cumulative raised
$218K$109K$0
Aug 11, 2023 · openedNov 20, 2023 · last reading
Target ($50K) hit — Aug 13, 2023, day 2Deadline Apr 29, 2024 — 161 days out

Left axis: cumulative dollars raised. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2021–FY2022 · hover for source
$14K
−$74K
FY2021
$82K
−$330K
FY2022
RevenueNet income
Metric
FY2021 unaudited
FY2022 unaudited
Income statement
Revenue
$14,092
$82,111
Cost of goods sold
-$5,661
$232,208
Gross margin
60%
-183%
Net income
-$74,140
-$329,989
Taxes paid
$0
$0
Balance sheet
Cash
$49,543
$4,177
Accounts receivable
$0
$20,302
Total assets
$187,479
$109,560
Short-term debt
$261,619
$32,562
Long-term debt
$0
$3,899
Total liabilities
$261,619
$36,461
Other
Headcount
—
3

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$10M

Offering details

Target$50,000
Max$124,000
Min investment$100
OpenedAug 11, 2023
DeadlineApr 29, 2024
ClosedNov 21, 2023
Days active102

Links & provenance

Source: Manual
0001670254-23-000730

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.